文献速递腹部CTMRPET

胰腺神经内分泌肿瘤影像学新前沿:包括影像组学更新

New frontiers in imaging including radiomics updates for pancreatic neuroendocrine neoplasms.
PubMed 文献 · Abdom Radiol (NY) · 2020-10-23

本文阐述常规MDCT、MRI(含DWI)、CT与MRI影像组学、FDG与DOTATATE PET-CT在胰腺神经内分泌肿瘤诊断、分期、分级、预后、治疗计划及疗效评估中的应用。背景指出GEP NENs治疗与预后取决于分期、原发部位及组织学分级,传统影像评估尚不足以替代手术和组织学评估,而定量影像特征及先进影像工具在更准确分期、风险分层、指导管理和评估疗效方面似乎有前景。

要点

  • GEP NENs的治疗与预后取决于肿瘤分期及组织学分级,新版WHO分类强调分级的重要性。
  • 传统影像评估尚不能提供足够信息替代手术和组织学评估。
  • DWI MRI、DOTATATE PET/CT及影像组学纹理分析等定量特征似乎有前景。

核心结论

  • GEP NENs的治疗和预后取决于肿瘤分期及组织学分级。
  • 传统影像评估用于诊断和分期尚不能产生足够信息替代手术和组织学评估。
  • 识别重要的定性影像特征并结合定量特征及先进影像工具(包括DWI MRI、DOTATATE PET/CT功能成像、影像组学纹理分析和放射基因组特征)似乎有前景,可用于更准确分期、肿瘤风险分层、指导管理和评估治疗反应。

研究设计与样本

  • 本文为阐述多种影像工具(包括常规MDCT、MRI含DWI、CT与MRI影像组学、FDG与DOTATATE PET-CT)在胰腺神经内分泌肿瘤中应用的综述性文章。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To illustrate the applications of various imaging tools including conventional MDCT, MRI including DWI, CT & MRI radiomics, FDG & DOTATATE PET-CT for diagnosis, staging, grading, prognostication, treatment planning and assessing treatment response in cases of pancreatic neuroendocrine neoplasms (PNENs).

BACKGROUND: Gastroenteropancreatic neuroendocrine neoplasms (GEP NENs) are very diverse clinically & biologically. Their treatment and prognosis depend on staging and primary site, as well as histological grading, the importance of which is also reflected in the recently updated WHO classification of GEP NENs. Grade 3 poorly differentiated neuroendocrine carcinomas (NECs) are aggressive & nearly always advanced at diagnosis with poor prognosis; whereas Grades-1 and 2 well-differentiated neuroendocrine tumors (NETs) can be quite indolent. Grade 3 well-differentiated NETs represent a new category of neoplasm with an intermediate prognosis. Importantly, the evidence suggest grade heterogeneity can occur within a given tumor and even grade progression can occur over time. Emerging evidence suggests that several non-invasive qualitative and quantitative imaging features on CT, dual-energy CT (DECT), MRI, PET and somatostatin receptor imaging with new tracers, as well as texture analysis, may be useful to grade, prognosticate, and accurately stage primary NENs. Imaging features may also help to inform choice of treatment and follow these neoplasms post-treatment.

CONCLUSION: GEP NENs treatment and prognosis depend on the stage as well as histological grade of the tumor. Traditional ways of imaging evaluation for diagnosis and staging does not yet yield sufficient information to replace operative and histological evaluation. Recognition of important qualitative imaging features together with quantitative features and advanced imaging tools including functional imaging with DWI MRI, DOTATATE PET/CT, texture analysis with radiomics and radiogenomic features appear promising for more accurate staging, tumor risk stratification, guiding management and assessing treatment response.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Saleh M, Bhosale PR, Yano M, et al. New frontiers in imaging including radiomics updates for pancreatic neuroendocrine neoplasms. Abdom Radiol (NY). 2020. PMID: 33095312. doi:10.1007/s00261-020-02833-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。